Vaccine Adjuvants Market to Reach USD 1478.32 Million by 2026 – Exclusive Report by Mordor Intelligence

October 27 23:26 2021
Vaccine Adjuvants Market to Reach USD 1478.32 Million by 2026 - Exclusive Report by Mordor Intelligence
Mordor Intelligence
North America is expected to observe tremendous growth in the vaccine adjuvants market over the forecast period. The major factors driving the vaccine adjuvants market’s growth in the North American region are the presence of key market players, the availability of advanced technologies, and the increasing expenditure on R&D for vaccines.

Vaccine Adjuvants Market Overview

The vaccine adjuvants market was valued at approximately USD 665.86 million in 2020, and it is expected to witness a revenue of USD 1478.32 million in 2026, with a CAGR of 13.37% over the forecast period, 2021-2026. The propelling factors for the growth of the vaccine adjuvants market include the unmet needs for vaccines against certain diseases, expanding government recommendations for immunizations, technological innovations, and increasing the use of recombinant subunit and synthetic vaccines.

Download free sample here – Vaccine Adjuvants Market

Impact of COVID-19 in Vaccine Adjuvants Market

According to a research article in Nature Reviews Immunology 2020, aluminum-based vaccine adjuvants offer a glide path to induce high levels of neutralizing antibody, which is increasingly recognized as a cornerstone of the protection afforded by COVID-19 vaccines. Additionally, in May 2020, GSK intended to produce 1 billion doses of its pandemic vaccine adjuvant system in 2021 to support the development of multiple adjuvanted COVID-19 vaccine candidates. Thus, the COVID-19 pandemic is expected to significantly impact the studied market growth positively.

Vaccine Adjuvants Market – Geographical Overview 

North America holds a significant share in the vaccine adjuvants market during the forecast period

The major factors driving the vaccine adjuvants market’s growth in the North American region are the presence of key market players, the availability of advanced technologies, and the increasing expenditure on R&D for vaccines. According to the Centers for Disease Control and Prevention (CDC), adjuvants such as aluminum hydroxyphosphate sulfate, monophosphoryl lipid A (MPL) + aluminum salt, oil-in-water emulsions composed of squalene, MPL, and QS-21 (a natural compound from Chilean soapbark tree combined in a liposomal formulation), and cytosine phosphoguanine (CpG) are currently used in vaccines such as DtaP (Daptacel, Infanrix), Hep A (Havrix, Vaqta), Hep B (Engerix-B, Recombivax), HPV (Gardasil 9), Pneumococcal (Prevnar 13), Cervarix, Fluad, Shingrix, and Heplisav-B in the United States. Furthermore, there has been a growing interest in adjuvant technology for the development of vaccines against COVID-19, and this scenario is expected to drive the studied market growth in the region during the pandemic.

Check our other latest reports on –

Key Highlights of the Vaccine Adjuvants Market

  • The vaccine adjuvants market is moderately consolidated and consists of many major players. Companies such as Adjuvatis, GlaxoSmithKline PLC, Croda International PLC, Merck KGaA, and Novavax Inc. are the key players. The major companies have conducted product launches, approvals, acquisitions, and collaborations for the development of novel vaccine adjuvants, thereby building a competitive landscape in the market.
  • The mineral salt-based adjuvants segment is expected to witness significant growth over the forecast period. Alum-based vaccine adjuvants are the most commonly and most widely used adjuvants for human vaccines. Aluminum-based salts are also being used for research purposes to increase the efficacy of vaccines.

Related Reports and Links

List of Key Players in the Vaccine Adjuvants Market

  • Adjuvance Tecchnologies Inc.
  • Adjuvatis
  • Agenus Inc.
  • Aphios Corporation
  • Chemtrade Logistics Inc.
  • Croda International PLC (Brenntag Biosector AS)
  • CSL Limited
  • Dynavax Technologies Corporation
  • GlaxoSmithKline PLC
  • InvivoGen
  • Merck KGaA
  • Novavax Inc.
  • OZ Biosciences
  • Pacific GeneTech Limited
  • Seppic (Air Liquide)
  • Thermo Fisher Scientific Inc.

*List Not Exhaustive 

Mordor Intelligence has segmented the global vaccine adjuvants market on the basis of type, usage, disease type, application, and geography:

  • Type (Market Size & Forecast based on Revenue (USD million), 2018-2026)
    • Mineral Salt-based Adjuvant
    • Tensoactive Adjuvants
    • Adjuvant Emulsions
    • Liposome Adjuvants
    • Carbohydrate Adjuvants
    • Bacteria-derived Adjuvants
    • Virus-like particles (VLP)
    • Other Types
  • Usage (Market Size & Forecast based on Revenue (USD million), 2018-2026)
    • Active Immunostimulants
    • Carriers
    • Vehicle Adjuvants
  • Disease Type (Market Size & Forecast based on Revenue (USD million), 2018-2026)
    • Infectious Disease
    • Cancer
  • Application (Market Size & Forecast based on Revenue (USD million), 2018-2026)
    • Research Applications
    • Commercial Applications
  • Geography (Market Size & Forecast based on Revenue (USD million) by Type, Route of Administration, Disease Type, and Application) 2018-2026)
    • Asia-Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • Rest of Asia-Pacific
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Germany
      • United Kingdom
      • Italy
      • France
      • Spain
      • Rest of Europe
    • Middle-East and Africa
      • GCC
      • South Africa
      • Rest of Middle-East and Africa
    • South America
      • Brazil
      • Argentina
      • Rest of South America

About Mordor Intelligence

Mordor Intelligence is a market intelligence and advisory firm. Our mission is to map complex business ecosystems across the globe to better predict butterfly effects. To date, we have partnered with 4000+ enterprises across 20 industries, to deliver precise data and actionable insights in over 6000 projects. Our domain-specific teams of research experts continuously track markets, enabling our clients to gain a competitive edge through high-quality market intelligence. 

We offer fully tailored intelligence solutions to meet the unique business requirements of any organization. Our deep industry expertise coupled with cross-functional analyst teams ensures we can support the intelligence requirements of even the most specific of business problems.

Media Contact
Company Name: Mordor Intelligence Private Limited
Contact Person: Bhargav P
Email: Send Email
Phone: +1 617-765-2493
Address:5th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli
City: Hyderabad
State: Telangana 500008
Country: India
Website: https://www.mordorintelligence.com/industry-reports/vaccine-adjuvants-market?utm_source=press-release&utm_medium=Outbound&utm_campaign=51331&utm_id=AB_Newswire&utm_content=PR1